Sanchez Sanchez, M. V., Ebensen, T., Schulze, K., Cargnelutti, D. E., Scodeller, E., & Guzmán, C. A. (2023). Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG. Web
Citación estilo ChicagoSanchez Sanchez, Maria Victoria, Thomas Ebensen, Kai Schulze, Diego Esteban Cargnelutti, Eduardo Scodeller, and Carlos A. Guzmán. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based On the Recombinant Nucleoprotein Co-Administered With a TLR2/6 Agonist BPPcysMPEG. 2023.
Cita MLASanchez Sanchez, Maria Victoria, et al. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based On the Recombinant Nucleoprotein Co-Administered With a TLR2/6 Agonist BPPcysMPEG. 2023.